首页|期刊导航|现代检验医学杂志|川崎病冠脉病变患者血清穿孔素与和肽素检测的早期诊断及对清热益气活血法治疗预后的价值评价

川崎病冠脉病变患者血清穿孔素与和肽素检测的早期诊断及对清热益气活血法治疗预后的价值评价OA

Evaluation of the Value of Serum Perforin and Copeptin Detection in Early Diagnosis of Kawasaki Disease with Coronary Artery Lesions and in Evaluation of Prognosis Following Qingre Yiqi Huoxue Therapy

中文摘要英文摘要

目的 探讨川崎病冠状动脉病变(KD-CAL)患者血清穿孔素与和肽素检测的早期诊断价值,分析两者对清热益气活血法治疗预后的价值.方法 选择2021年7月~2023年7月陕西省人民医院收治的120例KD患儿作为研究对象;采用彩色多普勒超声诊断仪检测冠脉内径并计算Z值,根据Z值将KD患儿分为KD无冠脉病变组(KD-nonCAL组,Z<2.5)和KD冠脉病变组(KD-CAL组,Z≥2.5),每组60例.所有患儿均采用清热益气活血方联合西药(IVIG+阿司匹林+双嘧达莫)的治疗方案,治疗4周后开展疗效评价,比较治疗前及治疗4周后外周血穿孔素、和肽素、炎性指标(IL-17A、TNF-α、PCT、CRP、ESR)和血常规指标(WBC、PLT、HCT).结果 与KD-nonCAL组比较,KD-CAL组的穿孔素、和肽素水平升高,炎性指标(IL-17A、TNF-α、PCT、CRP、ESR)、血常规指标(WBC和PLT)升高,HCT降低,差异具有统计学意义(t=-16.963~4.625,均P<0.05);相关性分析显示,Z值与KD患儿的穿孔素和和肽素水平显著正相关(r=0.646、0.621,均P<0.05);穿孔素、和肽素及二者联合诊断KD-CAL的ROC曲线下面积(AUC)分别为0.975、0.942和0.989.经清热益气活血方联合西药治疗4周后,共有显效67例,有效43例,无效10例,总有效率为91.67%;与显效+有效组比较,无效组的Z值、穿孔素、和肽素升高(t=-12.990、-16.902、-19.006,均P<0.05).多元线性回归分析显示,治疗前后的和肽素(B=0.043、Beta=0.300,t=3.013、P=0.003)、穿孔素(B=0.004、Beta=0.282,t=2.779、P=0.006)、CRP(B=0.011、Beta=0.205,t=2.134、P=0.035)差值均与Z值差值呈显著正相关.结论 穿孔素联合和肽素对KD-CAL具有较高诊断价值,同时和肽素、穿孔素、CRP是预测KD患儿清热益气活血法治疗后冠脉病变改善情况的重要因素.

Objective To investigate the value of serum perforin and copeptin detection in the early diagnosis of Kawasaki disease with coronary artery lesions(KD-CAL),and to analyze the value of the two indicators in evaluating the prognosis of patients treated with Qingre Yiqi Huoxue Therapy.Methods A total of 120 children with Kawasaki Disease(KD)admitted to Shaanxi Provincial People's Hospital from July 2021 to July 2023 were enrolled.Coronary artery diameter was measured by color Doppler echocardiography,and Z-scores were calculated.According to Z-score,the children with KD were divided into two groups:a KD group without coronary artery lesions(KD-nonCAL group,Z<2.5,n=60)and a KD group with coronary artery lesions(KD-CAL group,Z≥2.5,n=60).All children received the treatment regimen of Qingre Yiqi Huoxue Decoction combined with Western medicine(IVIG,aspirin,and dipyridamole).Efficacy evaluation was conducted after 4 weeks of treatment.Serum levels of perforin,copeptin,inflammatory indicators(IL-17A,TNF-α,PCT,CRP,ESR),and routine blood test indicators(WBC,PLT,HCT)were compared before treatment and 4 weeks after treatment.Results Compared with the KD-nonCAL group,the KD-CAL group showed significantly elevated levels of perforin,copeptin,inflammatory indexes(IL-17A,TNF-α,PCT,CRP,ESR),and routine blood test indexes(WBC,PLT),as well as significantly decreased HCT(t=-16.963 to 4.625,all P<0.05).Correlation analysis showed that Z-score was significantly positively correlated with the levels of perforin and copeptin(r=0.646 and 0.621,both P<0.05).The areas under the ROC curve(AUC)of perforin,copeptin,and their combination for diagnosing KD-CAL were 0.975,0.942,and 0.989,respectively.After 4 weeks of treatment with Qingre Yiqi Huoxue recipe combined with Western medicine,67 patients showed marked improvement,43 showed moderate improvement,and 10 showed no improvement,yielding a total response rate of 91.67%.Compared with the improved groups(marked+moderate),the non-improved group had significantly higher Z-scores,perforin,and copeptin levels(t=-12.990,-16.902,and-19.006,respectively,all P<0.05).Multiple linear regression analysis showed that the pre-to-post treatment differences in copeptin(B=0.043,Beta=0.300,t=3.013,P=0.003),perforin(B=0.004,Beta=0.282,t=2.779,P=0.006),and CRP(B=0.011,Beta=0.205,t=2.134,P=0.035)were all significantly positively correlated with the change in Z-score.Conclusions Perforin combined with copeptin has high value in the early diagnosis of KD-CAL,and copeptin,perforin,and CRP are important factors for predicting the improvement of coronary artery lesions in children with KD following Qingre Yiqi Huoxue treatment.

严晓华;万璐;高娜;穆志龙;贺望;万萱;马娟

陕西省人民医院 儿童病院,西安 710068西安市中医医院儿科,西安 710021陕西省人民医院 儿童病院,西安 710068陕西省人民医院 儿童病院,西安 710068陕西省人民医院 儿童病院,西安 710068陕西省人民医院 儿童病院,西安 710068陕西省人民医院 检验科,西安 710068

医药卫生

川崎病冠状动脉病变穿孔素和肽素清热益气活血方

Kawasaki diseasecoronary artery lesionsperforincopeptinQingre Yiqi Huoxue Recipe

《现代检验医学杂志》 2026 (5)

14-19,6

陕西省中医药管理局科研课题(2021-01-ZZ-014)陕西省中西医结合心血管病防治重点实验开放课题(2022XXG-YB-003)陕西省人民医院2022年科技人才项目(拔尖人才)(2022BJ-08).

10.3969/j.issn.1671-7414.2026.05.003

评论